Therapeutic effects of reduced glutathione on liver function, fibrosis, and HBV DNA clearance in chronic hepatitis B patients.
- 2025-02-07
- RCT · n = 90
- BMC gastroenterology 25(1)
- Qiyao Wei
- Jing Zhao
- PubMed: 39920583
- DOI: 10.1186/s12876-025-03600-z
- High evidence
- Clinical
ALT decreased from 348.96 ± 31.47 U/L to 31.11 ± 9.78 U/L in the observation group and from 347.90 ± 31.40 U/L to 56.90 ± 16.32 U/L in the control group (P < 0.05).
- Effect
- Beneficial
- Effect size
- Large
- Significant
- Yes